DK0864327T3 - Anvendelse af pyrimidinderivater til fremstilling af et lægemiddel til forebyggelse af kræft - Google Patents

Anvendelse af pyrimidinderivater til fremstilling af et lægemiddel til forebyggelse af kræft

Info

Publication number
DK0864327T3
DK0864327T3 DK98103410T DK98103410T DK0864327T3 DK 0864327 T3 DK0864327 T3 DK 0864327T3 DK 98103410 T DK98103410 T DK 98103410T DK 98103410 T DK98103410 T DK 98103410T DK 0864327 T3 DK0864327 T3 DK 0864327T3
Authority
DK
Denmark
Prior art keywords
preparation
pyrimidine derivatives
cancer prevention
prevention drug
drug
Prior art date
Application number
DK98103410T
Other languages
Danish (da)
English (en)
Inventor
Karl Dr Geisen
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Application granted granted Critical
Publication of DK0864327T3 publication Critical patent/DK0864327T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK98103410T 1997-03-13 1998-02-27 Anvendelse af pyrimidinderivater til fremstilling af et lægemiddel til forebyggelse af kræft DK0864327T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19710435A DE19710435A1 (de) 1997-03-13 1997-03-13 Verwendung von Pyrimidinderivaten zur Prävention von Krebs allein oder in Kombination mit anderen therapeutischen Maßnahmen

Publications (1)

Publication Number Publication Date
DK0864327T3 true DK0864327T3 (da) 2003-02-17

Family

ID=7823277

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98103410T DK0864327T3 (da) 1997-03-13 1998-02-27 Anvendelse af pyrimidinderivater til fremstilling af et lægemiddel til forebyggelse af kræft

Country Status (19)

Country Link
US (1) US6156755A (cs)
EP (1) EP0864327B1 (cs)
JP (1) JPH10279482A (cs)
KR (1) KR19980080148A (cs)
CN (1) CN1193513A (cs)
AR (1) AR011190A1 (cs)
AT (1) ATE227129T1 (cs)
AU (1) AU726089B2 (cs)
BR (1) BR9800884A (cs)
CA (1) CA2231765A1 (cs)
CZ (1) CZ74698A3 (cs)
DE (2) DE19710435A1 (cs)
DK (1) DK0864327T3 (cs)
ES (1) ES2182161T3 (cs)
HU (1) HUP9800535A1 (cs)
PL (1) PL325327A1 (cs)
PT (1) PT864327E (cs)
RU (1) RU2209629C2 (cs)
TR (1) TR199800436A3 (cs)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5438299A (en) 1998-08-29 2000-03-21 Astrazeneca Ab Pyrimidine compounds
ATE336484T1 (de) 1998-08-29 2006-09-15 Astrazeneca Ab Pyrimidine verbindungen
GB9828511D0 (en) 1998-12-24 1999-02-17 Zeneca Ltd Chemical compounds
GB9905075D0 (en) 1999-03-06 1999-04-28 Zeneca Ltd Chemical compounds
GB9907658D0 (en) 1999-04-06 1999-05-26 Zeneca Ltd Chemical compounds
GB9919778D0 (en) 1999-08-21 1999-10-27 Zeneca Ltd Chemical compounds
GB0004888D0 (en) 2000-03-01 2000-04-19 Astrazeneca Uk Ltd Chemical compounds
GB0004887D0 (en) 2000-03-01 2000-04-19 Astrazeneca Uk Ltd Chemical compounds
GB0004886D0 (en) 2000-03-01 2000-04-19 Astrazeneca Uk Ltd Chemical compounds
GB0004890D0 (en) 2000-03-01 2000-04-19 Astrazeneca Uk Ltd Chemical compounds
GB0007371D0 (en) 2000-03-28 2000-05-17 Astrazeneca Uk Ltd Chemical compounds
GB0016877D0 (en) 2000-07-11 2000-08-30 Astrazeneca Ab Chemical compounds
GB0021726D0 (en) 2000-09-05 2000-10-18 Astrazeneca Ab Chemical compounds
US6716851B2 (en) * 2000-12-12 2004-04-06 Cytovia, Inc. Substituted 2-aryl-4-arylaminopyrimidines and analogs as activators or caspases and inducers of apoptosis and the use thereof
BR0116493A (pt) * 2000-12-21 2003-09-30 Vertex Pharma Compostos de pirazol úteis como inibidores de proteìna cinase
GB0103926D0 (en) 2001-02-17 2001-04-04 Astrazeneca Ab Chemical compounds
GB0113041D0 (en) 2001-05-30 2001-07-18 Astrazeneca Ab Chemical compounds
US6825198B2 (en) * 2001-06-21 2004-11-30 Pfizer Inc 5-HT receptor ligands and uses thereof
TWI330183B (cs) * 2001-10-22 2010-09-11 Eisai R&D Man Co Ltd
GB0205690D0 (en) 2002-03-09 2002-04-24 Astrazeneca Ab Chemical compounds
WO2003076434A1 (en) 2002-03-09 2003-09-18 Astrazeneca Ab 4- imidazolyl substuited pyrimidine derivatives with cdk inhibitiory activity
GB0205688D0 (en) 2002-03-09 2002-04-24 Astrazeneca Ab Chemical compounds
GB0205693D0 (en) 2002-03-09 2002-04-24 Astrazeneca Ab Chemical compounds
RU2376992C2 (ru) * 2002-07-29 2009-12-27 Райджел Фармасьютикалз, Инк. Способы лечения или профилактики аутоиммунных заболеваний с помощью соединений 2,4-пиримидиндиамина
IL166241A0 (en) * 2002-07-29 2006-01-15 Rigel Pharmaceuticals Inc Method of treating or preventing autoimmune diseases with 2,4-pyrimidinedinediamine compounds
GB0311274D0 (en) 2003-05-16 2003-06-18 Astrazeneca Ab Chemical compounds
GB0311276D0 (en) 2003-05-16 2003-06-18 Astrazeneca Ab Chemical compounds
GB0323137D0 (en) * 2003-10-03 2003-11-05 Chang Lisa C W 2,4,6- Trisubstituted pyrimidines and their different uses
CA2551944A1 (en) * 2003-12-15 2005-06-30 Almirall Prodesfarma Ag 2, 6 bisheteroaryl-4-aminopyrimidines as adenosine receptor antagonists
TW200528101A (en) 2004-02-03 2005-09-01 Astrazeneca Ab Chemical compounds
DE602006020864D1 (de) * 2005-04-11 2011-05-05 Almirall Sa 2, 6-di-(hetero-)aryl-4-amido-pyrimidine als adenosin-rezeptor-antagonisten
US20060293343A1 (en) * 2005-05-18 2006-12-28 Asahi Kasei Pharma Corporation Pyrimidine derivatives
AU2006296386A1 (en) 2005-09-30 2007-04-05 Astrazeneca Ab Imidazo [1,2-a] pyridine having anti-cell-proliferation activity
WO2008070661A1 (en) * 2006-12-04 2008-06-12 Neurocrine Biosciences, Inc. Substituted pyrimidines as adenosine receptor antagonists
US20100249084A1 (en) * 2007-03-21 2010-09-30 Youngsheng Chen Substituted pyrimidines as adenosine receptor antagonists

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB884772A (en) * 1958-01-16 1961-12-20 Merck & Co Inc 2-alkoxy-4-amino pyrimidines
DE3905364A1 (de) * 1989-02-22 1990-08-23 Hoechst Ag Substituierte pyrimidin-derivate, verfahren zu ihrer herstellung und ihre verwendung als tool
DE4025387A1 (de) * 1990-08-10 1992-02-13 Hoechst Ag Substituierte pyrimidin-derivate, verfahren zu ihrer herstellung und ihre verwendung als reagenzien
WO1994007867A1 (en) * 1992-09-28 1994-04-14 Pfizer Inc. Substituted pyrimidines for control of diabetic complications

Also Published As

Publication number Publication date
BR9800884A (pt) 1999-12-07
TR199800436A2 (xx) 1998-10-21
PT864327E (pt) 2003-03-31
HU9800535D0 (en) 1998-04-28
HUP9800535A1 (hu) 2000-11-28
EP0864327A1 (de) 1998-09-16
RU2209629C2 (ru) 2003-08-10
CN1193513A (zh) 1998-09-23
TR199800436A3 (tr) 1998-10-21
US6156755A (en) 2000-12-05
AU5835098A (en) 1998-09-17
DE19710435A1 (de) 1998-09-17
ATE227129T1 (de) 2002-11-15
JPH10279482A (ja) 1998-10-20
AR011190A1 (es) 2000-08-02
ES2182161T3 (es) 2003-03-01
EP0864327B1 (de) 2002-11-06
DE59806139D1 (de) 2002-12-12
CZ74698A3 (cs) 1998-09-16
KR19980080148A (ko) 1998-11-25
CA2231765A1 (en) 1998-09-13
PL325327A1 (en) 1998-09-14
AU726089B2 (en) 2000-11-02

Similar Documents

Publication Publication Date Title
PT864327E (pt) Utilizacao de derivados de pirimidina para a preparacao de um medicamento para a prevencao do cancro
IS6310A (is) Kínasólínafleiður til lækninga
ID23874A (id) Obat
DE122010000011I1 (de) Flüssige gonadotropinhaltige Arzneimittel
NL300373I2 (nl) HIV-replicatie-remmende pyrimidinen
ATE256123T1 (de) Pyrimidonderivate
ID24654A (id) Formulasi farmasi omeprazola
ATE446955T1 (de) Chinazolinone derivate
DK1093370T3 (da) Farmaceutisk præparat til behandling af diabetes
PT1221918E (pt) Administracao de drogas sub-tenon
DK1158992T3 (da) Anvendelse af xenon til fremstilling af et farmaceutisk præparat til behandling af neurointoksikationer
EE200000383A (et) Peroraalne farmatseutiline pikendatud vabanemisega annusvorm
DK1147083T3 (da) Arylpiperazinyl-cyclohexylindolderivater til behandling af depression
DK0998272T3 (da) Farmaceutisk præparat til kombinationen piperidinoalkanoldekongestivum
ATE238812T1 (de) Voriconazol-enthaltende pharmazeutische zubereitungen
NO20040145L (no) Anvendelse av benzensulfonamidderivater for fremstilling av et medikament
DE69737936D1 (de) Arzneimittel
ATE432707T1 (de) Pharmazeutische zubereitung
EE05375B1 (et) LevosimendaniÁfarmatseutilineÁlahus
NO20001375L (no) Legemiddelformulering med kontrollert virkestoffrigivning
NO991560L (no) PDE IV-inhiberende 2-cyanoiminoimidazol-derivater
NO20012976L (no) Anvendelse av inhibitorer av KQTI-kanalen for fremstilling av et medikament
NO20014926D0 (no) Farmasöytiske forbindelser
DK0868911T3 (da) Rapamycinpræparater til oral indgivelse
DE69830154D1 (de) Pharmazeutische zusammensetzungen